View source for Landmark analysis of the TRITON-TIMI 38 trial demonstrates significant benefit with the loading and maintenance doses of prasugrel
Jump to navigation
Jump to search
You do not have permission to edit this page, for the following reason:
You can view and copy the source of this page.
Pages included on this page:
- Template:Cite journal (view source)
- Template:Main other (view source)
- Template:Reflist (view source)
- Template:WikiDoc Help Menu (view source)
- Template:WikiDoc Sources (view source)
- Module:Check for unknown parameters (view source)
- Module:Citation/CS1 (view source)
- Module:Citation/CS1/COinS (view source)
- Module:Citation/CS1/Configuration (view source)
- Module:Citation/CS1/Date validation (view source)
- Module:Citation/CS1/Identifiers (view source)
- Module:Citation/CS1/Suggestions (view source)
- Module:Citation/CS1/Utilities (view source)
- Module:Citation/CS1/Whitelist (view source)
- Module:Citation/CS1/styles.css (view source)